Abstract
In this study the co-assembly of two amphiphilic block copolymers with tailored composition and molecular characteristics, poly(ethylene oxide)-poly(ε-caprolactone)-b-poly(ethylene oxide) (PEO113-b-PCL35-b-PEO113) and poly(2-(dimethylamino)ethyl methacrylate)-b-poly(ε-caprolactone)-b-poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA20-b-PCL70-b-PDMAEMA20), was employed for preparation of a novel micellar system for controlled delivery of insulin. Mixed block copolymer micelles (MBCMs) of three different compositions were prepared by blending the two copolymers at molar ratios of 7:3, 1:1 and 3:7. Next, the electrostatic complexation between insulin and MBCMs with a focus on particle size, morphology, zeta potential and colloid stability as a function of insulin concentration in the aqueous solution was investigated by dynamic and electrophoretic light scattering as well as atomic force microscopy. The properties of systems were proven to depend on MBCMs composition and protein concentration. In vitro cytotoxicity of blank and insulin-loaded carriers was assessed by standard MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) test. The release profile of insulin from selected carriers in phosphate buffer (pH 7.4) was also studied.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.